News summary

A Micropeptide that Inhibits Vascular Calcification via PKM2 Degradation

Source: Fight Aging! • Published: 23 Oct 2026, 18:22

Summarized by Masters of Longevity from Fight Aging!.

Reports on a 40–amino-acid micropeptide that promotes PKM2 degradation to reduce metabolic reprogramming and slow vascular calcification in models.

A Micropeptide that Inhibits Vascular Calcification via PKM2 Degradation
Key Takeaways
  • Thus it is interesting to keep an eye on developments in this space.
  • Slowing is a start, but effective reversal of age-related tissue calcification remains a unfulfilled goal.
  • The vascular system is prone to calcification with advancing age.
Read the full article at Fight Aging! ↗

Continue exploring

Recommended MoL Picks

MoL PickThe Next Obesity-Drug Race Is About What Weight You LoseRegeneron’s myostatin and activin A antibodies point to a sharper question for the GLP-1 era: not whether people can lose more weight, but whether medicine can preserve the tissue that makes weight loss healthier.MoL PickSemaglutide Extended Lifespan in Mice. What Would Make It a Human Longevity Drug?A new animal study sharpens an important question: when do benefits in a particular disease become evidence for a longer, healthier life?MoL PickApoB: The cholesterol signal LDL can missIn longevity medicine, the useful biomarkers are not always the exotic ones. ApoB is a relatively simple blood test that can sharpen cardiovascular prevention when LDL-C looks reassuring but particle burden remains high.